E.coli-derived human PU.1/Spi1 recombinant protein (Position: E18-K196). Human PU.1/Spi1 shares 84% and 84.4% amino acid (aa) sequence identity with mouse and rat PU.1/Spi1, respectively.
Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation
Form:
Lyophilized
Target:
Transcription factor PU.1
Application Dilute:
Immunohistochemistry (Paraffin-embedded Section), 0.5-1µg/ml, Human, Mouse, Rat
IHC(P) analysis of Mouse Spleen Tissue using Anti-PU.1/Spi1 antibody.
Anti-PU.1/Spi1 antibody, IHC(P): Human Tonsil Tissue.
IHC(P) analysis of Rat Spleen Tissue using Anti-PU.1/Spi1 antibody.
